Thomas Édouard

Marfan Sartan: a randomized, double-blind, placebo-controlled trial

Olivier Milleron, Florence Arnoult, Jacques Ropers et al. · European Heart Journal · 2015 · 209 citations · Full text

MFAP5 Loss-of-Function Mutations Underscore the Involvement of Matrix Alteration in the Pathogenesis of Familial Thoracic Aortic Aneurysms and Dissections

Mathieu Barbier, Marie Sylvie Gross, Mélodie Aubart et al. · The American Journal of Human Genetics · 2014 · 135 citations · Full text

Mfap5 Loss-of-function Mutations, Genetics, Matrix Alteration +5

Effect of Beta-Blockade on Ascending Aortic Dilatation in Children With the Marfan Syndrome

Magalie Ladouceur, Christophe Fermanian, Jean‐Marc Lupoglazoff et al. · The American Journal of Cardiology · 2006 · 133 citations

Marfan Syndrome, Heart Failure, Cardiovascular Disease +10

Genetic disruption of the oncogenic HMGA2–PLAG1–IGF2 pathway causes fetal growth restriction

Walid Abi Habib, Frédéric Brioude, Thomas Édouard et al. · Genetics in Medicine · 2017 · 129 citations · Full text

Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature

Audrey De Rocca Serra-Nédélec, Thomas Édouard, Karine Tréguer et al. · Proceedings of the National Academy of Sciences · 2012 · 115 citations

Human Growth, Pathology, Insulin Signaling +16